As for the heterogeneity of BCR responsiveness, CLL cells could be divided into 3 subgroups of SHP-1low/pPLCG2high to SHP-1high/pPLCG2low expression, where each subset displayed unique deviations in their BCR signaling responses (71). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.